Response to a randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal

Authors


  • Funding sources
    None.

  • Conflicts of interest
    J.S. has received research support from Novartis. The remaining authors have no conflicts of interest to declare.

No abstract is available for this article.

Ancillary